{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T23:22:30Z","timestamp":1787440950482,"version":"build-2736575974"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","award":["450392965"],"award-info":[{"award-number":["450392965"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014542","name":"Software AG Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021729","name":"Medizinische Fakult\u00e4t der Albert-Ludwigs-Universit\u00e4t Freiburg","doi-asserted-by":"publisher","award":["2021\/A2-Fol"],"award-info":[{"award-number":["2021\/A2-Fol"]}],"id":[{"id":"10.13039\/501100021729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021729","name":"Medizinische Fakult\u00e4t der Albert-Ludwigs-Universit\u00e4t Freiburg","doi-asserted-by":"publisher","award":["2021\/B3-Fol"],"award-info":[{"award-number":["2021\/B3-Fol"]}],"id":[{"id":"10.13039\/501100021729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012353","name":"DKTK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012353","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biopha.2026.119478","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T22:54:12Z","timestamp":1780008852000},"page":"119478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Herbal hepatoprotective drugs modulate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-like spheroids and psoriasis-like keratinocytes"],"prefix":"10.1016","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0093-560X","authenticated-orcid":false,"given":"Ute","family":"W\u00f6lfle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Haarhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck Anicet","family":"Ditengou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3888-0931","authenticated-orcid":false,"given":"Ralf","family":"Weiskirchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7361-7734","authenticated-orcid":false,"given":"Giuseppe","family":"Rusignuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1195-055X","authenticated-orcid":false,"given":"Tobias","family":"Boettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1372-998X","authenticated-orcid":false,"given":"Christoph","family":"Schempp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119478_bib1","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119478_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","article-title":"The \u2018psoriatic march\u2019: a concept of how severe psoriasis may drive cardiovascular comorbidity","volume":"20","author":"Boehncke","year":"2018","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.biopha.2026.119478_bib3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jaad.2013.10.044","article-title":"Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study","volume":"70","author":"van der Voort","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.biopha.2026.119478_bib4","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/jdv.14470","article-title":"Methods report: European S3-Guideline on the systemic treatment of psoriasis vulgaris \u2013 Update Apremilast and Secukinumab \u2013 EDF in cooperation with EADV and IPC","volume":"31","author":"Dressler","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.biopha.2026.119478_bib5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/jdv.14673","article-title":"Immune response patterns in non-communicable inflammatory skin diseases","volume":"32","author":"Eyerich","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.biopha.2026.119478_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.941071","article-title":"Dendritic Cells and Macrophages in the Pathogenesis of Psoriasis","volume":"13","author":"Kamata","year":"2022","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119478_bib7","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1111\/j.1529-8019.2009.01281.x","article-title":"Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy","volume":"23","author":"Bardazzi","year":"2010","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.biopha.2026.119478_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/ijms17020217","article-title":"Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?","volume":"17","author":"Mantovani","year":"2016","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119478_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1214623","article-title":"Co-occurrence of non-alcoholic steatohepatitis exacerbates psoriasis associated with decreased adiponectin expression in a murine model","volume":"14","author":"Takezaki","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2026.119478_bib10","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.jid.2018.03.1522","article-title":"High-Fat Diet Exacerbates Early Psoriatic Skin Inflammation Independent of Obesity: Saturated Fatty Acids as Key Players","volume":"138","author":"Herbert","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.biopha.2026.119478_bib11","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.5114\/aoms.2019.89451","article-title":"Abnormal serum fatty acid profile in psoriatic arthritis","volume":"15","author":"Mysliwiec","year":"2019","journal-title":"Arch. Med Sci."},{"key":"10.1016\/j.biopha.2026.119478_bib12","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.3390\/nu15071698","article-title":"Modulation of Dietary Fatty Acids in an Open-Label Study Improves Psoriasis and Dampens the Inflammatory Activation Status","volume":"15","author":"Saalbach","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2026.119478_bib13","first-page":"517","article-title":"Non-alcoholic fatty liver disease and psoriasis \u2013 is there a shared proinflammatory network?","volume":"19","author":"Heitmann","year":"2021","journal-title":"JDDG J. der Dtsch. Dermatol. Ges."},{"key":"10.1016\/j.biopha.2026.119478_bib14","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/ptr.5667","article-title":"Non-alcoholic Fatty Liver Disease: Beneficial Effects of Flavonoids","volume":"30","author":"Akhlaghi","year":"2016","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2026.119478_bib15","doi-asserted-by":"crossref","first-page":"5713","DOI":"10.1002\/ptr.8347","article-title":"Silybin: A Review of Its Targeted and Novel Agents for Treating Liver Diseases Based on Pathogenesis","volume":"38","author":"Wu","year":"2024","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2026.119478_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/1099-1573(200102)15:1<58::AID-PTR805>3.0.CO;2-R","article-title":"Artichoke leaf extract reduces symptoms of irritable bowel syndrome in a post-marketing surveillance study","volume":"15","author":"Walker","year":"2001","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2026.119478_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.phymed.2006.07.001","article-title":"The active components and the pharmacological multi-target principle of STW 5 (Iberogast\u00ae)","volume":"13","author":"Wegener","year":"2006","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2026.119478_bib18","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1055\/s-0042-115177","article-title":"Topically Used Herbal Products for the Treatment of Psoriasis - Mechanism of Action, Drug Delivery, Clinical Studies","volume":"82","author":"Herman","year":"2016","journal-title":"Planta Med"},{"key":"10.1016\/j.biopha.2026.119478_bib19","article-title":"The Impacts of Herbal Medicines and Natural Products on Regulating the Hepatic Lipid Metabolism","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119478_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.apsb.2019.11.017","article-title":"Herbal drug discovery for the treatment of nonalcoholic fatty liver disease","volume":"10","author":"Yan","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2026.119478_bib21","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/ptr.6973","article-title":"Potential herbal constituents for psoriasis treatment as protective and effective therapy","volume":"35","author":"Dabholkar","year":"2021","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2026.119478_bib22","doi-asserted-by":"crossref","first-page":"15489","DOI":"10.3390\/ijms232415489","article-title":"Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment","volume":"23","author":"Guo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119478_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/2515690X211068826","article-title":"Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions","volume":"27","author":"Koltai","year":"2022","journal-title":"J. Evid. Based Integr. Med"},{"key":"10.1016\/j.biopha.2026.119478_bib24","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3390\/ijms20071629","article-title":"Human Multilineage 3D Spheroids as a Model of Liver Steatosis and Fibrosis","volume":"20","author":"Pingitore","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119478_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075692","article-title":"Genetic characteristics of the human hepatic stellate cell line LX-2","volume":"8","author":"Weiskirchen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2026.119478_bib26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0092-8674(75)90183-X","article-title":"Formation of a keratinizing epithelium in culture by a cloned cell line derived from a teratoma","volume":"6","author":"Rheinwald","year":"1975","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119478_bib27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3390\/biom11030371","article-title":"The Effect of Herbal Medicinal Products on Psoriasis-Like Keratinocytes","volume":"11","author":"Gendrisch","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2026.119478_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15892-7","article-title":"The psoriasis-associated IL-17A induces and cooperates with IL-36 cytokines to control keratinocyte differentiation and function","volume":"7","author":"Pfaff","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119478_bib29","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/mnfr.201500635","article-title":"Fructose and glucose combined with free fatty acids induce metabolic disorders in HepG2 cell: A new model to study the impacts of high-fructose\/sucrose and high-fat diets in vitro","volume":"60","author":"Zhao","year":"2016","journal-title":"Mol. Nutr. & Food Res."},{"key":"10.1016\/j.biopha.2026.119478_bib30","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1083\/jcb.100.3.965","article-title":"Nile red: a selective fluorescent stain for intracellular lipid droplets","volume":"100","author":"Greenspan","year":"1985","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2026.119478_bib31","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41587-023-01680-4","article-title":"Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis","volume":"41","author":"Hendriks","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119478_bib32","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C T method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2026.119478_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2023.102331","article-title":"Protocol for the generation and automated confocal imaging of whole multi-cellular tumor spheroids","volume":"4","author":"Genenger","year":"2023","journal-title":"STAR Protoc."},{"key":"10.1016\/j.biopha.2026.119478_bib34","doi-asserted-by":"crossref","DOI":"10.3791\/62280","article-title":"Staining and High-Resolution Imaging of Three-Dimensional Organoid and Spheroid Models","author":"Gonzalez","year":"2021","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.biopha.2026.119478_bib35","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1007\/s00204-019-02576-6","article-title":"Development of in vitro 3D cell model from hepatocellular carcinoma (HepG2) cell line and its application for genotoxicity testing","volume":"93","author":"\u0160tampar","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biopha.2026.119478_bib36","article-title":"Understanding the cellular interactome of non-alcoholic fatty liver disease","volume":"4","author":"Wallace","year":"2022","journal-title":"JHEP Rep."},{"key":"10.1016\/j.biopha.2026.119478_bib37","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s13238-013-2084-3","article-title":"NF-\u03baB and STAT3 signaling pathways collaboratively link inflammation to cancer","volume":"4","author":"Fan","year":"2013","journal-title":"Protein Cell"},{"key":"10.1016\/j.biopha.2026.119478_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155357","article-title":"Synergistic induction of IL-23 by TNF\u03b1, IL-17A, and EGF in keratinocytes","volume":"138","author":"Ehst","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2026.119478_bib39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2230.1988.tb01959.x","article-title":"The skin-liver connection","volume":"13","author":"Sarkany","year":"1988","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.biopha.2026.119478_bib40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/bjd.16239","article-title":"Nonalcoholic fatty liver disease in patients with psoriasis: a consequence of systemic inflammatory burden?","volume":"179","author":"Prussick","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.biopha.2026.119478_bib41","first-page":"118","article-title":"The Role of Oxidative Stress in the Induction and Development of Psoriasis","volume":"28","author":"Blagov","year":"2023","journal-title":"FBL"},{"key":"10.1016\/j.biopha.2026.119478_bib42","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s12325-020-01251-y","article-title":"Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review","volume":"37","author":"Gillessen","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.biopha.2026.119478_bib43","first-page":"23814","article-title":"p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release","volume":"275","author":"Craig","year":"2000","journal-title":"Evid. a Cytoprot. autocrine Signal. Pathw. a Card. myocyte Model Syst. J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119478_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111755","article-title":"The biological potential and health-benefits of flavonoids: A review and development opportunities","volume":"421","author":"Duarte","year":"2025","journal-title":"Chem. -Biol. Interact."},{"key":"10.1016\/j.biopha.2026.119478_bib45","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.3390\/molecules27165327","article-title":"Mechanistic Insights into the Pharmacological Significance of Silymarin","volume":"27","author":"Wadhwa","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2026.119478_bib46","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.phrs.2019.04.025","article-title":"Natural products in licorice for the therapy of liver diseases: Progress and future opportunities","volume":"144","author":"Li","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2026.119478_bib47","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.biopha.2018.08.094","article-title":"Chelidonine suppresses LPS-Induced production of inflammatory mediators through the inhibitory of the TLR4\/NF-\u03baB signaling pathway in RAW264.7 macrophages","volume":"107","author":"Liao","year":"2018","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2026.119478_bib48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/cld.522","article-title":"Silymarin in the treatment of liver diseases: What is the clinical evidence?","volume":"7","author":"Ferenci","year":"2016","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.biopha.2026.119478_bib49","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1039\/C6FO00773B","article-title":"Protective effects of glycyrrhizic acid from edible botanical Glycyrrhiza glabra against non-alcoholic steatohepatitis in mice","volume":"7","author":"Wang","year":"2016","journal-title":"Food & Funct."},{"issue":"5","key":"10.1016\/j.biopha.2026.119478_bib50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.phymed.2006.07.002","article-title":"Ex vivo\/in vitro absorption of STW 5 (Iberogast) and its extract components","volume":"13","author":"Kelber","year":"2006","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2026.119478_bib51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10354-012-0169-x","article-title":"STW 5 (Iberogast\u00ae)\u2014a safe and effective standard in the treatment of functional gastrointestinal disorders","volume":"163","author":"Ottillinger","year":"2013","journal-title":"Wien. Med Woche"},{"key":"10.1016\/j.biopha.2026.119478_bib52","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0887-2333(97)00078-7","article-title":"Antioxidant and hepatoprotective effects of artichoke extracts and constituents in cultured rat hepatocytes","volume":"11","author":"Gebhardt","year":"1997","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.biopha.2026.119478_bib53","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1078\/094471102321621278","article-title":"Choleretic activity and biliary elimination of lipids and bile acids induced by an artichoke leaf extract in rats","volume":"9","author":"Sa\u00e9nz Rodriguez","year":"2002","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2026.119478_bib54","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1089\/jmf.2021.K.0069","article-title":"Artichoke Extract Directly Suppresses Inflammation and Apoptosis in Hepatocytes During the Development of Non-Alcoholic Fatty Liver Disease","volume":"24","author":"Lee","year":"2021","journal-title":"J. Med Food"},{"issue":"5","key":"10.1016\/j.biopha.2026.119478_bib55","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.phymed.2006.07.002","article-title":"Ex vivo\/in vitro absorption of STW 5 (Iberogast) and its extract components","volume":"13","author":"Kelber","year":"2006","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2026.119478_bib56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3350\/cmh.2017.0039","article-title":"Picroside II attenuates fatty acid accumulation in HepG2 cells via modulation of fatty acid uptake and synthesis","volume":"24","author":"Dhami-Shah","year":"2018","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119478_bib57","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12944-024-02220-y","article-title":"Silymarin decreases liver stiffness associated with gut microbiota in patients with metabolic dysfunction-associated steatotic liver disease: a randomized, double-blind, placebo-controlled trial","volume":"23","author":"Jin","year":"2024","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.biopha.2026.119478_bib58","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13063-023-07210-6","article-title":"Efficacy of silymarin in patients with non-alcoholic fatty liver disease \u2014 the Siliver trial: a study protocol for a randomized controlled clinical trial","volume":"24","author":"Avelar","year":"2023","journal-title":"Trials"},{"key":"10.1016\/j.biopha.2026.119478_bib59","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3350\/cmh.2022.0040","article-title":"Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs","volume":"28","author":"Takamura","year":"2022","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119478_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/hep.26746","article-title":"IL-17 Signaling Accelerates the Progression of Nonalcoholic Fatty Liver Disease in Mice","volume":"59","author":"Harley","year":"2014","journal-title":"Hepatol. (Baltim. Md)"},{"key":"10.1016\/j.biopha.2026.119478_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01951-7","article-title":"A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates","volume":"11","author":"Str\u00f6bel","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119478_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260313","article-title":"Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study","volume":"16","author":"Goyale","year":"2021","journal-title":"PLOS ONE"},{"key":"10.1016\/j.biopha.2026.119478_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106679","article-title":"Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)","volume":"189","author":"Rizzo","year":"2023","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2026.119478_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004725","article-title":"\u03b2-Defensin-2 Protein Is a Serum Biomarker for Disease Activity in Psoriasis and Reaches Biologically Relevant Concentrations in Lesional Skin","volume":"4","author":"Jansen","year":"2009","journal-title":"PLOS ONE"},{"key":"10.1016\/j.biopha.2026.119478_bib65","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaci.2016.06.038","article-title":"\u03b2-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis","volume":"139","author":"Kolbinger","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.biopha.2026.119478_bib66","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.0022-202X.2005.23935.x","article-title":"High Expression Levels of Keratinocyte Antimicrobial Proteins in Psoriasis Compared with Atopic Dermatitis","volume":"125","author":"de Jongh","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.biopha.2026.119478_bib67","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/molecules24010123","article-title":"Modulation of Skin Inflammatory Response by Active Components of Silymarin","volume":"24","author":"Jur\u00e1\u0148ov\u00e1","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2026.119478_bib68","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/ijms19010171","article-title":"Psoriasis: A STAT3-Centric View","volume":"19","author":"Calautti","year":"2018","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119478_bib69","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jdermsci.2012.11.002","article-title":"NF-\u03baB: An essential transcription factor in psoriasis","volume":"69","author":"Goldminz","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.biopha.2026.119478_bib70","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2249.1995.tb05525.x","article-title":"IL-8\/IL-8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy","volume":"99","author":"Lemster","year":"1995","journal-title":"Clin. & Exp. Immunol."},{"key":"10.1016\/j.biopha.2026.119478_bib71","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1073\/pnas.86.16.6367","article-title":"Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes","volume":"86","author":"Grossman","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.119478_bib72","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/964069","article-title":"IL-6 as a Druggable Target in Psoriasis: Focus on Pustular Variants","volume":"2014","author":"Saggini","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.biopha.2026.119478_bib73","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jbspin.2012.06.010","article-title":"Successful effect of tocilizumab in anti-TNF-\u03b1-induced palmoplantar pustulosis in rheumatoid arthritis","volume":"79","author":"Rueda-Gotor","year":"2012","journal-title":"Jt. Bone Spine"},{"key":"10.1016\/j.biopha.2026.119478_bib74","article-title":"Psoriasis onset with tocilizumah","volume":"80","author":"Grasland","year":"2013","journal-title":"Jt. Bone Spine. Rev. du Rhum."},{"key":"10.1016\/j.biopha.2026.119478_bib75","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.20030451","article-title":"Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris","volume":"199","author":"Lee","year":"2004","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.biopha.2026.119478_bib76","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/17512433.2019.1657829","article-title":"Risankizumab for the treatment of psoriasis","volume":"12","author":"Gu","year":"2019","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119478_bib77","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(08)60726-6","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)","volume":"371","author":"Papp","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2026.119478_bib78","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.2147\/DDDT.S167149","article-title":"Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis","volume":"12","author":"Haugh","year":"2018","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.biopha.2026.119478_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2021.105162","article-title":"Influence of silymarin components on keratinocytes and 3D reconstructed epidermis","volume":"74","author":"Frankova","year":"2021","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.biopha.2026.119478_bib80","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/molecules24010123","article-title":"Modulation of Skin Inflammatory Response by Active Components of Silymarin","volume":"24","author":"Jur\u00e1\u0148ov\u00e1","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2026.119478_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13010098","article-title":"Silymarin and Inflammation: Food for Thoughts","volume":"13","author":"Surai","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2026.119478_bib82","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jpba.2007.06.026","article-title":"Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application","volume":"45","author":"Wu","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.biopha.2026.119478_bib83","first-page":"655","article-title":"Pharmacokinetic studies with silymarin in human serum and bile","volume":"6","author":"Lorenz","year":"1984","journal-title":"Methods Find. Exp. Clin. Pharm."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226005147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226005147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:46:37Z","timestamp":1787438797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226005147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":83,"alternative-id":["S0753332226005147"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119478","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Herbal hepatoprotective drugs modulate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-like spheroids and psoriasis-like keratinocytes","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119478"}}